SELAHATTIN KURTER: Open Payments
NPI 1164596615 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 84 payments from 15 companies in 2025. Trend: 2023 $811 · 2024 $987 · 2025 $1,529
Food & beverage: $1,411Education: $119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $225 |
| Alkermes, Inc. | 6 | $175 |
| Teva Pharmaceuticals USA, Inc. | 7 | $173 |
| E.R. Squibb & Sons, L.L.C. | 8 | $167 |
| Vanda Pharmaceuticals Inc. | 12 | $139 |
| Otsuka America Pharmaceutical, Inc. | 10 | $137 |
| Lundbeck LLC | 9 | $135 |
| Indivior Inc. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Orexo US, Inc. | 4 | $68 |
Products named: COBENFY, REXULTI, ARISTADA, FANAPT, MAVYRET, ABILIFY ASIMTUFII, VRAYLAR, SUBLOCADE.
Industry payments across WI — which companies pay providers there.
